Increased phosphorylation of STAT5b, but not STAT5a, in nasal polyps

American Journal of Rhinology and Allergy

Volumn 29, Issue 3, 2015, Pages 182-187

  Linke, Robert ^a   Pries, Ralph ^a   Könnecke, Michael ^a   Bruchhage, Karl Ludwig ^a   Böscke, Robert ^a   Gebhard, Maximilian ^a   Wollenberg, Barbara ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STAT5A PROTEIN; STAT5B PROTEIN; STAT5 PROTEIN; STAT5A PROTEIN, HUMAN; STAT5B PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NOSE MUCOSA; NOSE POLYP; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; TURBINATE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RHINITIS; SINUSITIS; TISSUE MICROARRAY; TRANSCRIPTION INITIATION;

GENE EXPRESSION; HUMANS; IMMUNOPRECIPITATION; NASAL POLYPS; PHOSPHORYLATION; RHINITIS; SINUSITIS; STAT5 TRANSCRIPTION FACTOR; TISSUE ARRAY ANALYSIS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS; TURBINATES;

EID: 84929717042     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2015.29.4170     Document Type: Article

References (36)

1. Van Crombruggen K, Zhang N, Gevaert P, et al. Pathogenesis of chronic rhinosinusitis: Inflammation. J Allergy Clin Immunol 128: 728-732, 2011.
2. Halawi AM, Smith SS, and Chandra RK. Chronic rhinosinusitis: Epidemiology and cost. Allergy Asthma Proc 34:328-334, 2013.
3. Chaaban MR, Walsh EM, and Woodworth BA. Epidemiology and differential diagnosis of nasal polyps. Am J Rhinol Allergy 27:473-478, 2013.
4. Georgy MS, and Peters AT. Chapter 7: Nasal polyps. Allergy AsthmaProc 33(suppl. 1):S22-S23, 2012.
5. Fokkens WJ, Lund VJ, Mullol J, Bachert C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 23:1- 298, 2012.
6. Schindler CW. Series introduction. JAK-STAT signaling in human disease. J Clin Invest 109:1133-1137, 2002.
7. Stark GR, and Darnell JE Jr. The JAK-STAT pathway at twenty. Immunity 36:503-514, 2012.
8. Schmitt-Ney M, Doppler W, Ball RK, and Groner B. Beta-casein gene promoter activity is regulated by the hormone-mediated relief of transcriptional repression and a mammary-gland-specific nuclear factor. Mol Cell Biol 11:3745-3755, 1991.
9. Liu X, Robinson GW, Gouilleux F, et al. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad SciUSA 92:8831-8835, 1995.
10. Lin JX, Mietz J, Modi WS, et al. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J Biol Chem 271:10738-10744, 1996.
11. Tang JZ, Zuo ZH, Kong XJ, et al. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior. Endocrinology 151:43-55, 2010.
12. Tan SH, and Nevalainen MT. Signal transducer and activator of transcription 5A/B in prostate and breast cancers. Endocr Relat Cancer 15:367-390, 2008.
13. Liao Z, Lutz J, and Nevalainen MT. Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer. Int J Biochem Cell Biol 42:186-192, 2010.
14. Cannady SB, Batra PS, Leahy R, et al. Signal transduction and oxidative processes in sinonasal polyposis. J Allergy Clin Immunol 120:1346-1353, 2007.
15. Cao Q, Zhang T, Jiang L, et al. Expression and significance of STAT3 and VEGF with MVD in the nasal polyps. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24:641-644, 647, 2010.
16. Kou W, Hu GH, Yao HB, et al. Transforming growth factor-β1 promotes Treg commitment in nasal polyposis after intranasal steroid treatment. Inflamm Res 62:283-289, 2013.
17. Wang XQ, Hu GH, Kou W, et al. Reciprocal roles of STAT3 and STAT5 in nasal polyposis. Am J Otolaryngol 33:741-752, 2012.
18. Linke R, Pries R, Könnecke M, et al. Increased activation and differentiated localization of native and phosphorylated STAT3 in nasal polyps. Int Arch Allergy Immunol 162:290-298, 2013.
19. Peters AT, Kato A, Zhang N, et al. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 125:397-403, 2010.
20. Cao Q, Zhang T, Wang L, et al. Expression of STAT6 in human nasal polyps and the relation between STAT6 and eosinophil infiltration. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 23:917-919, 922, 2009.
21. Goenka S, and Kaplan MH. Transcriptional regulation by STAT6. Immunol Res 50:87-96, 2011.
22. Weng L, Dai H, Zhan Y, et al. Rosetta error model for gene expression analysis. Bioinformatics 22:1111-1121, 2006.
23. Livak KJ, and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25:402-408, 2001.
24. Zhang N, Liu S, Lin P, et al. Remodeling and inflammation in Chinese versus white patients with chronic rhinosinusitis. J Allergy Clin Immunol 125:507-508, 2010.
25. Bachert C, Zhang N, Patou J, et al. Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol 8:34-38, 2008.
26. Lin JX, Li P, Liu D, et al. Critical role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity 36:586-599, 2012.
27. Yip SH, Eguchi R, Grattan DR, and Bunn SJ. Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a. J Neuroendocrinol 24:1484-1491, 2012.
28. Nadeau K, Hwa V, and Rosenfeld RG. STAT5b deficiency: An unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J Pediatr 158:701-708, 2011.
29. Furqan M, Mukhi N, Lee B, and Liu D. Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application. Biomark Res 1:5, 2013.
30. Du W, Wang YC, Hong J, et al. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species. J Cell Physiol 227:2421-2429, 2012.
31. Latha K, Li M, Chumbalkar V, et al. Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter. Int J Cancer 132:509-520, 2013.
32. Zhu J. Transcriptional regulation of Th2 cell differentiation. Immunol Cell Biol 88:244-249, 2010.
33. Kagami Si, Nakajima H, Kumano K, et al. Both stat5a and stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue. Blood 95:1370-1377, 2000.
34. Stout BA, Bates ME, Liu LY, et al. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol 173:6409-6417, 2004.
35. Qiu C, Peng WK, Shi F, and Zhang T. Bottom-up assembly of RNA nanoparticles containing phi29 motor pRNA to silence the asthma STAT5b gene. Genet Mol Res 11:3236-3245, 2012.
36. KleinJan A, Willart M, van Nimwegen M, et al. United airways: Circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation. Clin Exp Allergy 40:494-504, 2010.